Skip to main content
Clinical Trials/NCT04630912
NCT04630912CompletedNot Applicable

Acceptance and Commitment Therapy (ACT) for People With Dementia Experiencing Psychological Distress: a Hermeneutic Single Case Efficacy Design (HSCED) Series

University of Nottingham1 site in 1 country6 target enrollmentStarted: January 20, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
6
Locations
1
Primary Endpoint
Change in anxiety

Study Overview

Brief Summary

Introduction: People with dementia have a high prevalence of psychological distress but are under-served with evidence-based psychological interventions. To promote choice and improve clinical outcomes, there is a necessity to test different psychological intervention options for this population. Purpose: To investigate the effectiveness and acceptability of Acceptance and Commitment Therapy (ACT) for people with dementia, considering carer-supported, remote delivery and necessary therapy adaptations. Methods: A hermeneutic single case efficacy design (HSCED) series was used to analyse therapy process and change for three clients with dementia and psychological distress. Quantitative and qualitative data was collated ('rich case records') and analysed by three independent psychotherapy experts ('judges') who determined the outcome for each client. Results: Over the course of therapy, it was concluded that one client with dementia made positive changes, specifically reliable reductions in psychological distress, which were largely attributable to Acceptance and Commitment Therapy (ACT). Two clients remained unchanged. Discussion/Conclusion: Where change was achieved, the ACT-specific processes of values, committed action and acceptance, in combination with non-specific therapy factors including a strong client-carer relationship, existing client interests and individualised therapy adaptations, were facilitative of change. Hence, ACT may be feasible and effective by helping carers to better meet the needs of their loved ones with dementia. Future research to optimise ACT delivery in this population may be beneficial. Furthermore, the assessment of carer factors (e.g., their psychological flexibility, the client-carer relationship) may strengthen the evidence-base for systemic ACT-use.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Inclusion criteria for people with dementia
  • •Participants were included in the study if they had:
  • •A clinical diagnosis of dementia (any type)
  • •A clinically significant level of psychological distress (a score of ≥8 on the GAD-7 and ≥10 on the PHQ-9).
  • •Ability to give informed consent
  • •Inclusion criteria for caregiver of person with dementia
  • •Participants were included in the study if they:
  • •Cared for someone with a clinical diagnosis of dementia (any type)
  • •Were paid or unpaid and regularly supported them with activities of daily living
  • •Aged 18+ (no maximum age limit)
  • •Able to give informed consent

Exclusion Criteria

  • •Exclusion criteria for people with dementia
  • •Participants were excluded if they:
  • •Were already receiving psychotherapy
  • •Had insufficient English or language abilities to engage in therapy
  • •Were unable to consent to and/or engage in therapy
  • •Exclusion criteria for caregiver of person with dementia
  • •Participants were excluded if they:
  • •Had insufficient English or language abilities to support the person with dementia or engage in study/Change Interviews
  • •Were unable to consent to and/or engage in study

Arms & Interventions

Acceptance and Commitment Therapy

Experimental

12 weekly, 90 minute ACT sessions with person with dementia (with a review at week 6)

Intervention: Acceptance and Commitment Therapy (Other)

Outcomes

Primary Outcomes

Change in anxiety

Time Frame: Through study completion, up to 24 weeks

Generalised anxiety disorder questionnaire (GAD-7), scored 0-21, where higher scores indicate a greater severity of anxiety.

Change in depression

Time Frame: Through study completion, up to 24 weeks

Patient health questionnaire (PHQ-9), scored 0-27, where higher scores indicate a greater severity of depression.

Secondary Outcomes

  • Change in psychological flexibility(Through study completion, up to 24 weeks)
  • Change in wellbeing(Through study completion, up to 24 weeks)
  • Change in client problems(Through study completion, up to 24 weeks)
  • Change in therapeutic alliance(Through study completion, up to 12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials